Trained innate immunity, COVID-19 therapeutic dilemma, and fake science.
作者信息
Belizário José Ernesto
机构信息
Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.
出版信息
Clinics (Sao Paulo). 2020;75:e2124. doi: 10.6061/clinics/2020/e2124. Epub 2020 Jul 10.
Abstract
摘要
相似文献
1
Trained innate immunity, COVID-19 therapeutic dilemma, and fake science.
Clinics (Sao Paulo). 2020;75:e2124. doi: 10.6061/clinics/2020/e2124. Epub 2020 Jul 10.
2
BCG-induced trained immunity: can it offer protection against COVID-19?
Nat Rev Immunol. 2020 Jun;20(6):335-337. doi: 10.1038/s41577-020-0337-y.
3
Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again?
Future Oncol. 2020 Jul;16(19):1323-1325. doi: 10.2217/fon-2020-0381. Epub 2020 May 14.
4
COVID-19: the new challenge for rheumatologists. First update.
Clin Exp Rheumatol. 2020 May-Jun;38(3):373-382. doi: 10.55563/clinexprheumatol/yvn0nh. Epub 2020 May 26.
5
The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
Przegl Epidemiol. 2020;74(2):290-302. doi: 10.32394/pe.74.22.
6
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Allergy. 2020 Jul;75(7):1815-1819. doi: 10.1111/all.14345. Epub 2020 Jun 8.
7
COVID-19 vaccination clinical trials should consider multiple doses of BCG.
Pharmazie. 2020 Apr 6;75(4):159. doi: 10.1691/ph.2020.0444.
8
Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Asian Pac J Allergy Immunol. 2020 Sep;38(3):150-161. doi: 10.12932/AP-310520-0863.
9
Cell-Free Therapies: Novel Approaches for COVID-19.
Front Immunol. 2020 Sep 18;11:583017. doi: 10.3389/fimmu.2020.583017. eCollection 2020.
10
Immunology of COVID-19: Current State of the Science.
Immunity. 2020 Jun 16;52(6):910-941. doi: 10.1016/j.immuni.2020.05.002. Epub 2020 May 6.
引用本文的文献
1
Super-rapid race for saving lives by developing COVID-19 vaccines.
J Integr Bioinform. 2021 Mar 25;18(1):27-43. doi: 10.1515/jib-2021-0002.
本文引用的文献
1
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
Lancet. 2020 May 22. doi: 10.1016/S0140-6736(20)31180-6.
2
SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults.
JAMA. 2020 Jun 9;323(22):2340-2341. doi: 10.1001/jama.2020.8189.
3
Is BCG vaccination causally related to reduced COVID-19 mortality?
EMBO Mol Med. 2020 Jun 8;12(6):e12661. doi: 10.15252/emmm.202012661. Epub 2020 May 26.
4
Considering BCG vaccination to reduce the impact of COVID-19.
Lancet. 2020 May 16;395(10236):1545-1546. doi: 10.1016/S0140-6736(20)31025-4. Epub 2020 Apr 30.
5
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
6
Defining trained immunity and its role in health and disease.
Nat Rev Immunol. 2020 Jun;20(6):375-388. doi: 10.1038/s41577-020-0285-6. Epub 2020 Mar 4.
7
Immunological memory.
Immunol Cell Biol. 2019 Aug;97(7):615-616. doi: 10.1111/imcb.12280. Epub 2019 Jul 8.
8
BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity.
Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5. doi: 10.1016/j.chom.2017.12.010.
9
Why clinical trial outcomes fail to translate into benefits for patients.
Trials. 2017 Mar 14;18(1):122. doi: 10.1186/s13063-017-1870-2.
10
Practical and conceptual issues of clinical trial registration for Brazilian researchers.
Sao Paulo Med J. 2016 Jan-Feb;134(1):28-33. doi: 10.1590/1516-3180.2014.00441803. Epub 2015 Aug 21.
Zotero 插件